University of Ottawa Building Innovation Network to Accelerate Patents & Commercialization Opportunities

Universities generally face challenges when attempting to accelerate the patent and commercialization process in the biomedical and health sector. Most promising, early-stage study results never make it out of the lab, despite the possibility of breakthrough results in the real world. What if the ideas were further cultivated and embraced by sponsors with the capital, know-how, and wherewithal to commercialize biomedical products? A foreboding gap stands between an initial idea or preliminary study and the critical follow-up investigations necessary to support IND-enabling studies for example. Of course, these latter studies lead to investigational new drug applications (IND) and the human studies necessary to determine if the health product works. Some universities embrace concentrated efforts, such as programs to facilitate and support medically-focused investigators. One such initiative now unfolds at the University of Ottawa (uOttawa) Faculty of Medicine known as the Path to Patenting & Pre-commercialization (3P) grant program.

The Program

uOttawa now gets serious about driving the patenting and commercialization process for the most impactful health and biomedical r…

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).